Pulmonary extra-medullary hematopoiesis and pulmonary hypertension from underlying polycythemia vera: A case series

25Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Myeloproliferative neoplasia (MPN)-associated pulmonary hypertension (PH) is included in group five of the most recent clinical classification of PH.1 The MPNs are a heterogeneous group of disorders that includes disorders with primary expression of a myeloid phenotype and disorders characterized by expression of the Janus Kinase 2 (JAK2) mutation, p.V617F. The latter includes essential thrombocytosis, polycythemia vera, and idiopathic myelofibrosis.2 Pulmonary extra-medullary hematopoiesis (EMH) refers to the presence of hematopoietic precursor cells in the lung. It is a rare complication associated with myelofibrosis. Here we present a case series highlighting the clinical–pathological–radiological features of pulmonary EMH and PH from underlying polycythemia vera.

Cite

CITATION STYLE

APA

Singh, I., Mikita, G., Green, D., Risquez, C., & Sanders, A. (2017). Pulmonary extra-medullary hematopoiesis and pulmonary hypertension from underlying polycythemia vera: A case series. Pulmonary Circulation, 7(1), 261–267. https://doi.org/10.1177/2045893217702064

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free